세계의 메토프롤롤 주석산염 시장 보고서(2025년)
Metoprolol Tartrate Global Market Report 2025
상품코드 : 1825813
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

메토프롤롤 주석산염 시장 규모는 향후 몇 년 동안 안정적으로 성장할 것으로 예상됩니다. 2029년에는 CAGR 4.5%로 79억 7,000만 달러로 성장할 것입니다. 예측 기간의 성장은 맞춤형 의료, 심혈관질환 관리에 대한 의학 교육 및 훈련 강화, 효율적인 의약품 유통망 개발, 환자 교육 프로그램, 심혈관 연구를 위한 자금 증가 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 소비자 행동 분석, 공급망 최적화, 맞춤형 의약품 제조를 위한 3D 프린팅 기술 개발, 모바일 건강 앱 개발 및 사용 증가 등이 있습니다.

향후 5년간 4.5%의 성장률 전망은 지난번 예측보다 0.5% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과는 인도와 헝가리에서 수입되는 베타차단제 원료의약품(API)과 주사제 비용을 상승시켜 고혈압 조절을 저해하고 순환기내과 약값을 인상시킬 수 있기 때문에 미국의 순환기 의료를 혼란에 빠뜨릴 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

메토프롤롤 주석산염 시장의 성장은 고혈압 유병률의 증가에 의해 주도될 것으로 예상됩니다. 고혈압은 생활습관, 유전, 기초 건강 문제의 영향을 받는 복합적인 질환으로 서서히 발병하고 식습관, 운동 부족, 비만, 스트레스, 노화 등의 요인에 의해 악화됩니다. 메토프롤롤 주석산염은 심박수와 심박출량을 감소시켜 혈압을 낮춰 고혈압을 관리합니다. 예를 들어, 호주 통계청은 2023년 12월에 2022년 인구의 11.6%, 약 300만 명이 고혈압을 앓고 있으며, 이는 메토프롤롤 주석산염 시장 성장의 중요한 원동력이 되고 있음을 강조하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Metoprolol tartrate is a beta-blocker medication primarily prescribed for managing conditions such as high blood pressure, angina (chest pain), heart failure, and as part of treatment following a heart attack. It functions by blocking the effects of natural chemicals such as epinephrine on the heart and blood vessels, thereby reducing blood pressure, heart rate, and cardiac strain. Additionally, metoprolol tartrate is used to prevent migraine headaches.

The medication is available for administration through oral and injectable routes. Oral metoprolol tartrate refers to formulations taken by mouth, typically in tablet or capsule form, and is utilized in treating hypertension, cardiovascular issues, and other medical conditions. Distribution channels for metoprolol tartrate include hospital pharmacies, retail pharmacies, and online pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The metoprolol tartrate market research report is one of a series of new reports from The Business Research Company that provides metoprolol tartrate market statistics, including the metoprolol tartrate industry global market size, regional shares, competitors with metoprolol tartrate market share, detailed metoprolol tartrate market segments, market trends, and opportunities, and any further data you may need to thrive in the metoprolol tartrate industry. These metoprolol tartrate market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The metoprolol tartrate market size has grown steadily in recent years. It will grow from $6.41 billion in 2024 to $6.68 billion in 2025 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to rising awareness about hypertension, expansion and improvement of healthcare systems, early patent protections, and health initiatives.

The metoprolol tartrate market size is expected to see steady growth in the next few years. It will grow to $7.97 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to personalized medicine, enhanced medical education and training on the management of cardiovascular diseases, development of efficient drug distribution networks, patient education programs and increased funding for cardiovascular research. Major trends in the forecast period include consumer behavior analysis, supply chain optimization, development of 3D printing technologies for customizable drug formulations, increasing development and use of mobile health apps.

The forecast of 4.5% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. cardiovascular care by increasing costs for beta-blocker Active Pharmaceutical Ingredients(APIs) and injectable formulations imported from India and Hungary, potentially compromising hypertension control and raising cardiology medication expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the metoprolol tartrate market is expected to be driven by the rising prevalence of hypertension. Hypertension, a complex condition influenced by lifestyle, genetics, and underlying health issues, can develop gradually and is exacerbated by factors such as poor diet, lack of exercise, obesity, stress, and an aging population. Metoprolol tartrate manages hypertension by reducing heart rate and cardiac output, thereby lowering blood pressure. For example, the Australian Bureau of Statistics reported in December 2023 that 11.6% of the population, or approximately 3.0 million people, had hypertension in 2022, highlighting the significant driver behind the metoprolol tartrate market's growth.

The growing prevalence of coronary heart disease is expected to drive the expansion of the metoprolol tartrate market in the coming years. Coronary heart disease occurs when the blood vessels supplying the heart become narrowed due to plaque buildup, leading to reduced blood flow to the heart muscle, which can result in chest pain or even heart attacks. This condition is often caused by factors such as sedentary lifestyles, poor dietary choices, smoking, obesity, high blood pressure, and diabetes. Metoprolol tartrate helps manage coronary heart disease by lowering heart rate and blood pressure, preventing angina, protecting against acute coronary events, improving long-term health outcomes, and managing arrhythmias. For example, in October 2024, the Centers for Disease Control and Prevention (CDC) reported that one person dies every 33 seconds from cardiovascular disease, with 702,880 deaths from heart disease in 2022 alone, making it the cause of one in every five deaths. As a result, the rising prevalence of coronary heart disease is expected to boost the demand for metoprolol tartrate.

Leading companies in the metoprolol tartrate market are focusing on developing generic equivalents to offer cost-effective alternatives to branded medications for treating hypertension and cardiovascular conditions. These bioequivalent products provide the same therapeutic effects as their branded counterparts, ensuring similar absorption rates into the bloodstream. For example, Lupin Pharmaceuticals received approval from the FDA in August 2023 to market a generic equivalent of Toprol-XL Tablets, expanding their range of generic cardiovascular treatments in the U.S. market. This strategic approach aims to meet diverse patient needs with various tablet strengths indicated for hypertension and angina pectoris treatment.

Major companies operating in the metoprolol tartrate market are Pfizer Inc., AstraZeneca plc, Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Aurobindo Pharma, Cipla Inc., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals, Glenmark Pharmaceuticals Ltd., Emcure Pharmaceuticals Ltd., Alembic Pharmaceuticals Inc., Accord Healthcare Inc., Beximco Pharmaceuticals Ltd., Micro Labs Ltd., Inventia Healthcare Pvt. Ltd., Watson Laboratories Inc., Aizant Drug Research Solutions Pvt. Ltd., Zydus Cadila, Validus Pharmaceuticals LLC, Strides Pharma Science Limited, APO-MEDIX Pty Ltd.

North America was the largest region in the metoprolol tartrate market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metoprolol tartrate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the metoprolol tartrate market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The metoprolol tartrate market consists of sales of extended-release tablets, lopressor, and intravenous formulations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metoprolol Tartrate Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metoprolol tartrate market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for metoprolol tartrate ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The metoprolol tartrate market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Metoprolol Tartrate Market Characteristics

3. Metoprolol Tartrate Market Trends And Strategies

4. Metoprolol Tartrate Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Metoprolol Tartrate Growth Analysis And Strategic Analysis Framework

6. Metoprolol Tartrate Market Segmentation

7. Metoprolol Tartrate Market Regional And Country Analysis

8. Asia-Pacific Metoprolol Tartrate Market

9. China Metoprolol Tartrate Market

10. India Metoprolol Tartrate Market

11. Japan Metoprolol Tartrate Market

12. Australia Metoprolol Tartrate Market

13. Indonesia Metoprolol Tartrate Market

14. South Korea Metoprolol Tartrate Market

15. Western Europe Metoprolol Tartrate Market

16. UK Metoprolol Tartrate Market

17. Germany Metoprolol Tartrate Market

18. France Metoprolol Tartrate Market

19. Italy Metoprolol Tartrate Market

20. Spain Metoprolol Tartrate Market

21. Eastern Europe Metoprolol Tartrate Market

22. Russia Metoprolol Tartrate Market

23. North America Metoprolol Tartrate Market

24. USA Metoprolol Tartrate Market

25. Canada Metoprolol Tartrate Market

26. South America Metoprolol Tartrate Market

27. Brazil Metoprolol Tartrate Market

28. Middle East Metoprolol Tartrate Market

29. Africa Metoprolol Tartrate Market

30. Metoprolol Tartrate Market Competitive Landscape And Company Profiles

31. Metoprolol Tartrate Market Other Major And Innovative Companies

32. Global Metoprolol Tartrate Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Metoprolol Tartrate Market

34. Recent Developments In The Metoprolol Tartrate Market

35. Metoprolol Tartrate Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기